Article ID Journal Published Year Pages File Type
10918083 Radiotherapy and Oncology 2015 6 Pages PDF
Abstract
A strong survival impact of the ratio of PD-1+/CD8+ TILs was observed in EHBD cancer. In the poor prognostic subgroup, the blockade of the immune checkpoint in combination with conventional multimodality treatment needs to be considered.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , , , , , , , , ,